Only for one clinical trial.
Tim Steffens
From: optimal-bounce@xxxxxxxxxxxxx [mailto:optimal-bounce@xxxxxxxxxxxxx] On
Behalf Of Paula Morris
Sent: Friday, April 24, 2015 12:35 PM
To: optimal@xxxxxxxxxxxxx
Subject: [optimal] (no subject)
Hello colleagues,
I have received an inquiry from the UK about how often Spectralis users in the
US enter the c-curve information when imaging clinical patients, not just in
clinical trials.
Thanks so much for sharing,
P
**********************************************************
Electronic Mail is not secure, may not be read every day, and should not be
used for urgent or sensitive issues